For more than a decade, most women asking about hip resurfacing heard the same answer: not for you. The reasoning was sound at the time. Metal-on-metal bearings wore faster at the smaller sizes most women need, and the cobalt and chromium debris they released was of particular concern in women of child-bearing age. The operation, for most women, was effectively closed.
That position has now changed, and the change has been formalised in a series of regulatory and institutional milestones over the past eighteen months.
The H1 ceramic resurfacing implant, developed at Imperial College London, received approval from the Medicines and Healthcare products Regulatory Agency. A monoblock, anatomically contoured ceramic-on-ceramic implant, it was developed to bring ceramic resurfacing to women and smaller-framed patients.
MatOrtho's ReCerf, the ceramic-on-ceramic resurfacing implant with the longest clinical track record, received its CE mark, confirming compliance with European safety and performance standards and widening availability across the UK, Europe and internationally.
The Royal Orthopaedic Hospital in Birmingham, one of Europe's largest specialist orthopaedic centres, now offers ceramic-on-ceramic hip resurfacing, and the H1 began its wider European rollout. Ceramic resurfacing has moved from early adoption into mainstream specialist practice.
The Royal Orthopaedic Hospital reported its first female ceramic hip resurfacing patient, operated on by Mr Shakir Hussain. Her decision and her recovery are told in her patient story.
The first ReCerf ceramic hip resurfacing at Harborne Hospital, Birmingham was performed by Mr Shakir Hussain, extending ceramic resurfacing to a second of the practice's three hospitals. The full story is on the main practice site.
Every constraint that closed hip resurfacing to women was a property of the metal-on-metal bearing, not of the operation itself. Ceramic-on-ceramic bearings release no cobalt or chromium, so the metal-ion concern that dominated the conversation for women of child-bearing age simply does not arise. Ceramic is also among the lowest-wearing of all artificial joint surfaces, which matters most to the younger patients who stand to benefit most from resurfacing in the first place.
The size problem has been solved too. Ceramic-on-ceramic resurfacing covers the range of native head sizes that once excluded most women: ReCerf, with published five-year outcomes that include a substantial proportion of female patients, spans that range, and H1 is a further ceramic option in the field. The anatomy that once excluded most women is now covered.
What remains unchanged is everything that made resurfacing attractive in the first place: the femoral head is reshaped and capped rather than removed, native bone is preserved for the decades ahead, the hip retains its natural size and stability, and return to higher-impact activity, including running and racquet sports, is realistic. The full picture for female patients, including pregnancy and child-bearing questions, is set out on the hip resurfacing for women page.
It is fair to say that ceramic resurfacing implants are newer than the metal designs they replace, and any practice that pretends otherwise is not being straight with you. Both ReCerf and H1 are enrolled in the UK's Beyond Compliance programme, an independent surveillance scheme that tracks the performance of newly introduced implants in greater depth than standard registry follow-up. Every patient who receives one becomes part of a closely monitored cohort, and emerging signals are reviewed by an independent panel rather than by the manufacturer alone.
The data so far is encouraging. ReCerf has published five-year outcomes with low revision rates, and an international multicentre cohort of ceramic-on-ceramic resurfacing has reported reassuring two-year results. That is shorter than the twenty-year record of the older metal implants in men, and the right response to that gap is exactly what Beyond Compliance provides: structured, independent, long-term follow-up.
For a woman weighing the options, the comparison is not between a new implant and a proven one. Metal-on-metal resurfacing was never proven in women; it was withdrawn for them. The comparison is between a ceramic resurfacing designed around the historic failure modes and a conventional total hip replacement. For the right candidate, that is a conversation worth having with the imaging on the screen.
Resurfacing is a volume game: outcomes track surgeon experience more closely than almost any other factor in joint surgery.
Meet the SurgeonThis practice has performed more than 400 hip resurfacings across two implant systems, Adept and ReCerf, from consulting rooms at three Birmingham hospitals. For women, the ceramic-on-ceramic ReCerf is the bearing offered here, settled on weight-bearing imaging in clinic. H1, the other British ceramic resurfacing, is a newer option in the field. Metal-on-metal resurfacing is not offered to women here under any circumstances.
If you were assessed for resurfacing years ago and turned away, that assessment was made against constraints that no longer exist. If you have been offered a total hip replacement as the only option and you are young, active and otherwise well, a second opinion now costs you little and may change the next thirty years. Start with the candidacy criteria, or go straight to booking.
A private consultation with imaging review will establish, plainly, whether ceramic hip resurfacing is the right operation for you, which implant suits your anatomy, and what realistic recovery looks like.
Book a Consultation